Crystallographic fragment screening of CDK2-cyclin A: FragLites map sites of protein-protein interaction
Hope, I., Martin, M.P., Waring, M.J., Noble, M.E.M., Endicott, J.A., Tatum, N.J.To be published.
Content-Length: 167235 | pFad | http://rcsb.org/structure/9ETP
Experimental Data Snapshot
Starting Model: experimental
View more details
wwPDB Validation 3D Report Full Report
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
Cyclin-dependent kinase 2 | 302 | Homo sapiens | Mutation(s): 0 Gene Names: CDK2, CDKN2 EC: 2.7.11.22 | ![]() | |
UniProt & NIH Common Fund Data Resources | |||||
Find proteins for P24941 (Homo sapiens) Explore P24941 Go to UniProtKB: P24941 | |||||
PHAROS: P24941 GTEx: ENSG00000123374 | |||||
Entity Groups | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | P24941 | ||||
Sequence AnnotationsExpand | |||||
|
Entity ID: 2 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
Cyclin-A2 | 268 | Bos taurus | Mutation(s): 0 Gene Names: CCNA2 | ![]() | |
UniProt | |||||
Find proteins for P30274 (Bos taurus) Explore P30274 Go to UniProtKB: P30274 | |||||
Entity Groups | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | P30274 | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 1 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
BYZ (Subject of Investigation/LOI) Query on BYZ | E [auth A] F [auth A] G [auth A] H [auth A] I [auth A] | 4-bromo-1H-pyrazole C3 H3 Br N2 WVGCPEDBFHEHEZ-UHFFFAOYSA-N |
Modified Residues 1 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Type | Formula | 2D Diagram | Parent |
TPO Query on TPO | A, C | L-PEPTIDE LINKING | C4 H10 N O6 P | THR |
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 73.864 | α = 90 |
b = 133.717 | β = 90 |
c = 147.866 | γ = 90 |
Software Name | Purpose |
---|---|
REFMAC | refinement |
xia2 | data reduction |
Aimless | data scaling |
PHASER | phasing |
Funding Organization | Location | Grant Number |
---|---|---|
Medical Research Council (MRC, United Kingdom) | United Kingdom | MR/N009738/1 |
Medical Research Council (MRC, United Kingdom) | United Kingdom | MR/V029142/1 |
Cancer Research UK | United Kingdom | C2115/A21421 |